ELIZABETH SHPALL to Pandemics
This is a "connection" page, showing publications ELIZABETH SHPALL has written about Pandemics.
Connection Strength
0.053
-
A Randomized, Placebo-Controlled, Phase II Trial of Intravenous Allogeneic Non-HLA Matched, Unrelated Donor, Cord Blood Infusion for Ischemic Stroke. Stem Cells Transl Med. 2024 Feb 14; 13(2):125-136.
Score: 0.030
-
Migratory Pulmonary Infiltrates in a Patient With COVID-19 Infection and the Role of Corticosteroids. Mayo Clin Proc. 2020 09; 95(9):2038-2040.
Score: 0.023